Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
April 24, 2025
New assay enables high-resolution spatial visualization of protein interactions, unlocking functional insights within complex tissues MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of cutting-edge life science tools, today announced an Early Access Program for its latest advancement in spatial biology: a powerful new assay for in situ detection of protein proximity. Built upon Advanced [...]
Stellaromics Announces First Deployment of Pyxa Platform in Europe
April 24, 2025
Early Access Partnership with Dr. Nigel Jamieson to Explore 3D Spatial Biology in Oncology Research BOSTON -- Stellaromics, a pioneer in 3D spatial biology, today announced that Dr. Nigel Jamieson and his team at the University of Glasgow are the first European users of the company's Pyxa platform. As an inaugural early access partner, Dr. Jamieson, a physician-scientist and Professor at the University of [...]
1Cell.Ai and BioSkryb Announce Strategic Partnership to Advance Single Cell Multi-omics Innovation
April 24, 2025
FOSTER CITY, Calif. and DURHAM, N.C. -- 1Cell.Ai, a global leader in single cell precision diagnostics, has joined forces with BioSkryb Genomics, a pioneer in single cell multi-omics, to co-develop and commercialize next-generation single cell multi-omic solutions. This collaboration will empower researchers and clinicians to detect and characterize rare mutations in single cells with unprecedented accuracy, facilitating breakthroughs in cancer [...]
April 24, 2025
Company to present four abstracts at the American Association for Cancer Research 2025 annual meeting highlighting research from AVITI24, the Trinity™ workflow solution, and new direct in sample sequencing applications SAN DIEGO -- Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced the accelerated rollout and availability of direct in [...]
April 24, 2025
RESEARCH TRIANGLE PARK, N.C. -- Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of its manufacturing-grade IsoTag™ AAV reagent for the purification of Adeno-associated Virus (AAV) vectors. As indicated during the launch of the research-grade reagent in October 2024, this final advancement in product grade now includes production with validated processes and [...]
April 24, 2025
New relationships with Cold Spring Biotech, SCRUM and DaonBS in APAC will enable many more laboratories to adopt Syncell technology TAIPEI, Taiwan & LIVERMORE, Calif. -- Syncell, a leader in next-generation subcellular protein purification and spatial proteomics analysis, announced the launch of their preferred partner network today. The company’s commercial expansion includes new services partners [...]
EpiCypher Launches Novel, Affordable DNA Methylation Sequencing Assays to Accelerate Drug Discovery
April 24, 2025
Durham, NC – EpiCypher®, a leader in epigenomics innovation, announces the launch of CUTANA® meCUT&RUN and Multiomic CUT&RUN, two novel DNA methylation sequencing technologies advancing the frontiers of genomic research and drug discovery. These tools build upon EpiCypher’s proven CUT&RUN platform – a targeted nuclease strategy that has revolutionized chromatin profiling by enabling high-resolution mapping [...]
April 24, 2025
Expanded suite of consumables, instruments and services designed to empower researchers and accelerate next-generation drug development Ninety posters and presentations at AACR powered by the Standard BioTools proteomic portfolio to advance cancer research from target discovery to clinical development SOUTH SAN FRANCISCO, Calif. -- Standard BioTools Inc. (NASDAQ: LAB) today announced the launch of new and enhanced [...]
April 24, 2025
Adds to robust offering of NGS tools enabling exome sequencing, whole genome sequencing, RNA sequencing, deep sequencing for liquid biopsy research and MRD, and methylation detection Diverse portfolio of adapter sets now includes industry leading number of unique indexes at 3,072 HT UDI Adapters Enables multiplexing and high throughput sequencing SOUTH SAN FRANCISCO, Calif. -- [...]
Araceli Biosciences Closes $11.2M Seed Financing to Change the Pace of Drug Discovery
April 24, 2025
PORTLAND, Ore. — Araceli Biosciences, a pioneering biotechnology company revolutionizing high-content imaging and AI-powered analysis, today announced the successful completion of its Seed funding round, raising $7.2 million in new equity investment and converting $4.0 million in SAFEs, bringing total financing since Araceli’s spinout from Phoseon Technology to $11.2M. This funding will accelerate Araceli’s commercial expansion, scale manufacturing, and advance its [...]

